Description
Asia Pac HealthTech ecosystem momentum continues unabated closing at the mid year point at US$2.5B invested, building on the back of a record breaking 2018. Early stage ventures deal activity shrinks yet further, whereas total Series B and C deal value continues to grow, grabbing 69% of total funding, raising questions regarding the sustainability of the deal flow of Growth stage investors.
